Press "Enter" to skip to content

New patent for Astellas drug VESICARE LS

0
Copyright © DrugPatentWatch. Originally published at New patent for Astellas drug VESICARE LS

Annual Drug Patent Expirations for VESICARE+LS
Annual Drug Patent Expirations for VESICARE+LS

Vesicare Ls is a drug marketed by Astellas and is included in one NDA. It is available from one supplier.

The generic ingredient in VESICARE LS is solifenacin succinate. One supplier is listed for this compound. Additional details are available on the solifenacin succinate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Astellas drug VESICARE LS
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions